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Antionette L. Williams and Brenda L. Bohnsack*
Neural crest cells (NCCs) are vertebrate-specific transient, multipotent,
migratory stem cells that play a crucial role in many aspects of embryonic
development. These cells emerge from the dorsal neural tube and
subsequently migrate to different regions of the body, contributing to the
formation of diverse cell lineages and structures, including much of the
peripheral nervous system, craniofacial skeleton, smooth muscle, skin
pigmentation, and multiple ocular and periocular structures. Indeed,
abnormalities in neural crest development cause craniofacial defects and
ocular anomalies, such as Axenfeld-Rieger syndrome and primary congenital
glaucoma. Thus, understanding the molecular regulation of neural crest
development is important to enhance our knowledge of the basis for
congenital eye diseases, reflecting the contributions of these progenitors to
multiple cell lineages. Particularly, understanding the underpinnings of neural
crest formation will help to discern the complexities of eye development, as
these NCCs are involved in every aspect of this process. In this review, we
summarize the role of ocular NCCs in eye development, particularly focusing
on congenital eye diseases associated with anterior segment defects and the
interplay between three prominent molecules, PITX2, CYP1B1, and retinoic
acid, which act in concert to specify a population of neural crest-derived
mesenchymal progenitors for migration and differentiation, to give rise to
distinct anterior segment tissues. We also describe recent findings implicating
this stem cell population in ocular coloboma formation, and introduce recent
evidence suggesting the involvement of NCCs in optic fissure closure and
vascular development.
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Introduction
Neural crest cells (NCCs) are a population of multipo-
tent embryonic stem cells that give rise to a wide range
of cell and tissue types throughout the body. During
gastrulation, NCCs originate at the neural plate border
and migrate from folds of the neural ectoderm as the
neuroepithelium closes to form the neural tube (Beebe
and Coats, 2000; Creuzet et al., 2005; Whikehart, 2010).
These cells subsequently migrate, pervading different
regions of the embryo and yielding a broad range of tis-
sues (from myofiboblasts, melanocytes, endocrine cells,
neurons, and glial cells to cartilage and bone) (Beebe
and Coats, 2000; Creuzet et al., 2005; Whikehart, 2010).
Both migratory routes and derivatives of neural crest
vary with rostrocaudal position along the neural tube.
The vagal crest, derived from the caudal hindbrain, con-
tributes to the heart, and together with the sacral neu-
ral crest, also form the enteric nervous system that
innervates the gut (Creuzet et al., 2005). At the cephalic
level, NCCs form the mesectoderm, which subsequently
gives rise to craniofacial connective, dermal and skele-
tal tissues, neurons, and the cranial ganglia (Creuzet
et al., 2005; Gage et al., 2005; Kish et al., 2011) (Fig. 1).
With respect to ocular development, the NCCs migrating
to the eye are primarily derived from the prosencepha-
lon (developing forebrain) and mesencephalon (devel-
oping midbrain) (Whikehart, 2010). These cells give
rise to portions of the corneal endothelium and stroma,
iris stroma, ciliary body stroma and muscles, and tra-
becular meshwork of the eye (Hay, 1980; Beebe and
Coats, 2000; Cvekl and Tamm, 2004; Gage et al., 2005;
Whikehart, 2010; Kish et al., 2011;).
While the NCCs are migrating from the edge of the
neural tube, the neuroectodermal-derived optic sulci
appear as shallow pits along the neural plate and form the
optic vesicles that protrude laterally from the prosence-
phalon until apposed to the surface ectodermal-derived
optic placode (Creuzet et al., 2005) (Fig. 2). Concomitant
with surface ectoderm thickening for the differentiation of
the lens, morphogenetic movements involving the invagi-
nation of the optic vesicles leads to formation of a bi-
layered optic cup (Beebe and Coats, 2000; Creuzet et al.,
2005; Harada et al., 2007; Whikehart, 2010; Kish et al.,
2011).
A loose array of neuroectoderm-derived cranial NCCs,
termed the periocular mesenchyme (POM), migrate around
the posterior of the optic cup. In humans, the NCC
migrates in three waves, while in mice and chick there
appears to be only two waves (Johnston et al., 1979; Hay,
1980; Gage et al., 2005;). In humans, the first wave of
NCCs migrates into the space between the anterior surface
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of the lens and the surface ectoderm destined to form the
corneal epithelium to form the corneal endothelium (Gage
et al., 2005; Whikehart, 2010) (Fig. 3). A second wave of
cells migrates between the corneal epithelium and endo-
thelium to become the keratinocytes of the corneal stroma.
The corneal epithelium synthesizes components of the
extracellular matrix for the formation of primary stroma
when the lens detaches from the surface ectoderm, while
a third wave of NCCs migrates to the angle between the
posterior cornea (endothelium) and the anterior edge of
the optic cup, eventually contributing to the ciliary body
and iris stroma (Gage et al., 2005; Whikehart, 2010) (Fig.
3). The POM located in the tissues anterior to the chamber
angle between the anterior edge of the eye cup and the
endothelium initially remains undifferentiated at this
stage, but subsequently develops into flat endothelial-like
cells, comprising the trabecular meshwork and Schlemm’s
canal, respectively (Gage et al., 2005; Whikehart, 2010)
(Fig. 3).
Further development of the optic cup involves distinct
regionalized differentiation into at least four different
structures, including the retina, the retinal pigment epithe-
lium (RPE), the iris epithelium, and the ciliary epithelium
(Fig. 3). Notably, a second essential function of the POM
during ocular development is to provide essential signals
for the patterning of ocular ectoderm primordia, which
not only includes the specification of the RPE from the
optic cup, but also the induction of lacrimal glands from
the surface ectoderm and the differentiation of the optic
stalk from the neural ectoderm (Fuhrmann et al., 2000;
Gage et al., 2005; Kao et al., 2013). Moreover, cells origi-
nating from the surface epithelium interact with the POM
for proper eyelid development (Le Lievre and Le Douarin,
1975).
Over the last decade, studies have highlighted the con-
tributions of the NCCs to ocular and periocular develop-
ment, emphasizing the importance of these cells in
vertebrate ocular evolution. Indeed, defects in neural crest
formation lead to severe craniofacial defects and ocular
anomalies, and a comprehensive understanding of the inter-
actions involved in the molecular regulation of the neural
crest would provide insight into the complexities underlying
congenital eye diseases. Herein, we discuss the role of ocu-
lar NCCs in eye development, particularly focusing on con-
genital eye diseases associated with anterior segment
defects and the interplay between three prominent mole-
cules, PITX2, CYP1B1, and retinoic acid (RA), which act in
concert to specify a population of neural crest-derived mes-
enchymal progenitors for migration and differentiation to
give rise to distinct anterior segment tissues. We also
describe recent findings suggesting a role for NCCs in ocu-
lar fissure closure and blood vessel formation and introduce
recent evidence suggesting the involvement of NCCs in optic
fissure closure and vascular angiogenesis.
FIGURE 1. Migration pathways of NCCs in the developing neural tube. The
migratory routes and derivatives of NCCs vary with rostrocaudal position along
the neural tube. The vagal crest, derived from the caudal hindbrain, contrib-
utes to the heart, and together with the sacral neural crest, also forms the
enteric nervous system that innervates the gut. At the cephalic level, NCCs
form the mesectoderm, which subsequently gives rise to craniofacial connec-
tive, dermal and skeletal tissues, neurons, and the cranial ganglia. With
respect to ocular development, the NCCs migrating to the eye are primarily
derived from the prosencephalon (developing forebrain and brainstem) and
mesencephalon (developing midbrain).
FIGURE 2. Cell migration pattern to the optic cup during eye development.
NCCs are indicated in blue and mesodermal cell are indicated in red.
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Anterior Segment Dysgenesis: Ocular Anomalies
Associated With NCC Defects
The abnormal migration of NCCs and subsequent disrup-
tion of their derivative structures has been implicated in
congenital eye diseases affecting the anterior segment of
the eye. Anterior segment dysgenesis (ASD) encompasses
a group of developmental disorders affecting the function
of structures in front of the vitreous surface of the eye,
including the cornea, iris, lens, ciliary body, trabecular
meshwork, Schlemm’s canal, and sclera (Sowden, 2007).
Increasing evidence has shown that transcriptional events
are critical for many aspects of neural crest development,
and the pathogenesis of several anterior segment disor-
ders has been associated with defects in these genes.
AXENFELD-RIEGER SYNDROME AND PITX2
Axenfeld-Rieger syndrome (ARS) describes a rare (1 in
200,0000) group of genetically and phenotypically heterol-
ogous disorders that primarily affect the eye and are also
associated with systemic issues, including cardiovascular
outflow malformations, craniofacial and dental defects,
umbilical abnormalities, and pituitary anomalies with
endocrine sequelae (MacDonald et al., 2004; Evans and
Gage, 2005; Bohnsack et al., 2012). Ophthalmic manifesta-
tions of ARS are typically limited to varying degrees of
ASD and include posterior embryotoxon (anteriorization of
the angle structures into peripheral cornea) and iris hypo-
plasia (MacDonald et al., 2004; Evans and Gage, 2005;
Sowden, 2007; Bohnsack et al., 2012). Maldevelopment of
the iris results in corectopia (pupil displacement) and pol-
ycoria (multiple pupils) (Sowden, 2007). Further, abnormal
iris strands can extend from the iris to the posterior
embryotoxon, thereby covering the trabecular meshwork
in the iridocorneal angle and resulting in glaucoma in
50% of affected individuals (Gage et al., 1999; MacDon-
ald et al., 2004; Sowden, 2007; Bohnsack et al., 2011).
Molecular genetics studies have identified specific gene
mutations, and one of the most commonly affected genes
is paired-like homeodomain 2 (PITX2) on chromosome
4q25 (Vaux et al., 1992; Semina et al., 1996, 1997). More
than 45 point and chromosomal mutations, including both
gain- and loss-of-function of the PITX2 gene, have been
identified. ARS is typically inherited in an autosomal domi-
nant pattern, indicating that eye development is highly
sensitive to alterations in PITX2 expression and function.
PITX2, a member of the homeobox protein family, is a
transcription factor that plays a critical role in early devel-
opment, particularly in the formation of structures in the
anterior segment of the eye. In mice, Pitx2 is expressed in
the cranial neural crest-derived POM, but not in ocular tis-
sues derived from the neural and surface ectoderm (Gage
et al., 1999; Evans and Gage, 2005). Pitx2 knockout mice
die early in embryonic development, as a result of heart
defects and display severe ocular defects, loss of extraocular
muscles (EOMs), and jaw and pharyngeal arch abnormal-
ities (Gage et al., 1999). Due to this severe lethal phenotype,
conditional knockout studies in mice were used to demon-
strate the specific requirement of Pitx2 in the cranial neural
crest for optic stalk formation and development of the cor-
neal endothelium and stroma and sclera (Evans and Gage,
2005). Similarly, in zebrafish, we have found that knock-
down of Pitx2 or expression of a dominant negative mutant
form of the gene disrupted neural crest migration into the
craniofacial region (unpublished data) and caused malfor-
mation of the jaw, pharyngeal arches, corneal endothelium,
and iris stroma (Bohnsack et al., 2012). Thus, Pitx2 is criti-
cal in the cranial neural crest, and disruption in gene func-
tion or expression results in craniofacial and ocular
malformations.
The regulation of PITX2 expression in the cranial neural
crest is critical for ocular development. The essential
morphogen, RA has been shown in both mice and zebrafish
to regulate Pitx2 expression in the POM (Duester, 2009). RA
is derived from vitamin A (retinal) through a series of enzy-
matic reactions and exists as locally regulated gradients that
control numerous embryonic processes (Schier and Needle-
man, 2009; Bohnsack et al., 2012; Bohnsack and Kahana,
2013). In the craniofacial region, the developing eye pro-
duces RA in a specific spatial and temporal pattern
(Reijntjes et al., 2004). In mice, chick, and zebrafish, RA syn-
thesis enzymes (e.g., RALDH2, RALDH3, RALDH4) are
expressed in the developing dorsal and ventral retina, while
RA degradation enzymes (e.g., CYP26A1 and CYP26C1) are
localized to the cranial and caudal retina; thus, creating RA
gradients that are centered around the dorsal and ventral
axis of the eye (Molotkov et al., 2006; Cvekl and Wang,
2009; Duester, 2009) (Fig. 4). While systemic disruption of
RA levels are embryonic lethal and cause severe pan-ocular
malformations, localized alterations of RA signaling show
FIGURE 3. Overview of the embryonic derivatives in the developing eye. Sur-
face ectodermal-derived structures in green, neural ectodermal-derived struc-
tures in purple, neural crest-derived structures in blue, and mesoderm-
derived structures in red.
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that the POM is the primary target that regulates anterior
segment development (Kumar and Duester, 2010). In the
POM, RA binds to RA receptors (RARs b and c subunits)
which then heterodimerize with the retinoid X receptor
(RXR) a subunit. This nuclear hormone receptor complex
then upregulates the expression of Pitx2 in the POM (Evans
and Gage, 2005; Matt et al., 2005; Diehl et al., 2006; Kumar
and Duester, 2010; Lupo et al., 2011). In zebrafish, neural
crest-derived corneal endothelial and iris stromal malforma-
tions induced by decreased RA synthesis were rescued by
overexpression of human PITX2 (Bohnsack et al., 2012).
Thus, PITX2 is a functional downstream target of RA in the
POM, which mediates RA regulation of neural crest deriva-
tives in the eye. Clinical mutations in PITX2 in individuals
with ARS illustrate the essential role of the neural crest in
ocular development (Weisschuh et al., 2006; Acharya et al.,
2009). Animal studies demonstrate that Pitx2 along with RA
signaling in the neural crest-derived POM is a critical regu-
lator of anterior segment development and understanding
these developmental mechanisms yield insight into the
pathogenesis of this and other congenital eye diseases.
PRIMARY CONGENITAL GLAUCOMA AND CYP1B1
Disruption of neural crest development as seen in ASD
often results in abnormal iridocorneal angle and trabecu-
lar meshwork formation leading to early onset glaucoma
(Sowden, 2007). Situations in which elevated intraocular
pressure is directly due to the isolated finding of trabecu-
lar meshwork malformation are typically classified as pri-
mary congenital glaucoma (PCG), an uncommon
(1:10,000) autosomal-recessive eye disease diagnosed
between birth and 1 year of age (Vasiliou and Gonzalez,
2008). Elevated intraocular pressure in PCG damages the
optic nerve, cornea, and sclera leading to vision loss. PCG
is genetically heterologous, however, linkage studies and
positional cloning have implicated the gene for cytochrome
P4501B1 (CYP1B1) on chromosome 2p22.2, as the most
commonly identified PCG-causing gene (Mashima et al.,
2001; Hollander et al., 2006; Chavarria-Soley et al., 2008;
Badeeb et al., 2014). Multiple missense and nonsense
mutations, deletions, insertions and/or duplications, and
silent mutations in CYP1B1 account for 10–20% of cases
of PCG (Vasiliou and Gonzalez, 2008). Despite its associa-
tion with human disease, the definitive role of CYP1B1 in
eye development remains unknown.
The CYP1B1 gene encodes a cytochrome p450 enzyme
that catalyzes the monooxygenation of exogenous toxins,
such as polycyclic aromatic hydrocarbons in zebrafish, and
endogenous substrates, such as 17b estradiol in hormone-
induced tumors. In zebrafish embryos, early cyp1b1
expression in the retina occurs independently of the toxin-
induced activation of the aryl hydrocarbon receptor, sug-
gesting an as yet unidentified endogenous substrate for
cyp1b1 in the eye (Yin et al., 2008). In vitro studies have
demonstrated that Cyp1b1 alone is sufficient to efficiently
oxidize retinol to retinal and subsequently to RA in a
dehydrogenase-independent pathway (Chambers et al.,
2007). Further, expression of the Cyp1b1 ortholog in chick
is associated with RA activity during early development
(Chambers et al., 2007). In zebrafish, we have found that
cyp1b1 was expressed in a specific spatial and temporal
pattern in the dorsal and ventral retina in areas that over-
lapped with the RA synthesis enzymes, raldh2 and raldh3
(Figs. 4 and 5A–C). Further, we found that alterations in
Cyp1b1 levels correlated with response of a RA reporter
in the periocular tissues (Figs. 5D–H). Despite these find-
ings, knockdown of Cyp1b1 in zebrafish embryos showed
an early delay in neural crest-derived iris stromal forma-
tion (Figs. 5I–L) and retinal development that recovered
by the larval stage. Cyp1b1 deficient mice also did not
exhibit a consistent phenotype as intraocular pressures
were normal, despite mild angle abnormalities involving
Schlemm’s canal, the trabecular meshwork, cornea, and
iris. Thus, additional studies are required to determine
whether RA mediates the molecular effects of CYP1B1 in
neural crest and eye development.
CONGENITAL OCULAR COLOBOMA AND THE NEURAL CREST
During the early stages of eye formation, invagination of
the optic vesicle generates a bilayered optic cup with a
FIGURE 4. Schematic showing the regulation of RA synthesis in ocular devel-
opment. At early stages of development, RA synthesis enzymes (e.g.,
RALDH2, RALDH3, RALDH4) are expressed in the developing dorsal and
ventral retina, while RA degradation enzymes (e.g., CYP26A1 and CYP26C1)
are localized to the cranial and caudal retina; thus, creating RA gradients cen-
tered around the dorsal and ventral axis of the eye. Interestingly, in zebrafish,
cyp1b1 is expressed in a specific spatial and temporal pattern in the dorsal
and ventral retina, similar to the RA synthesis enzymes, raldh2 and raldh3.
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groove along the ventral margin. This groove, named the
optic fissure (also known as choroidal fissure or embry-
onic fissure), is essential for the entry of mesenchyme cells
that give rise to blood vessels that nourish the eye
throughout the life of the organism (Harada et al., 2007).
Subsequently, the margins of the optic cup close around
these vessels. In humans, the optic fissure closes during
the 6–7th weeks of gestation (Barishak, 1992), while in
mice and zebrafish, the fissure closes between 11 and 13
days post fertilization (dpf) and 1.5–2.5 dpf, respectively
(Chang et al., 2006). Failure of fissure closure results in
colobomas that affect the iris, lens, zonules, ciliary body,
retina, choroid, and optic nerve of the eye, and occur in
1 in 10,000 births (Shah et al., 2011, 2012). As this con-
dition also affects the major tissues of the anterior seg-
ment of the developing eye, it is appropriate to discuss
coloboma formation with respect to ASD, specifically high-
lighting the implications for the involvement of NCCs in
choroid fissure closure.
Ocular coloboma can be seen in isolation or as part of a
multisystem syndrome associated with other ocular abnor-
malities, such as microphthalmia (small, disorganized
globe), glaucoma, Peters anomaly, and cataract, in the
absence of systemic findings (Chang et al., 2006; Shah
et al., 2011, 2012). CHARGE, which is characterized by
defects affecting the eyes, heart, brain, craniofacial struc-
ture, and genitourinary system, is the most common syn-
drome associated with colobomas (Porges et al., 1992;
Eccles and Schimmenti, 1999; Morrison et al., 2000,
2002b; Guirgis and Lueder, 2003; Gregory-Evans et al.,
2004; Chang et al., 2006). However, there are numerous
chromosomal abnormalities and syndromes with unknown
genetic causes that also exhibit colobomas. In these syn-
dromic cases, the eye phenotype is observed concomitant
with craniofacial abnormalities, further supporting the idea
that NCCs play a role in the pathophysiology of colobomas
(Morrison et al., 2002a; Gregory-Evans et al., 2004;).
Studies in model organisms, primarily mice and zebra-
fish, suggest that genetic lesions or toxic exposures can
lead to abnormal dorsoventral patterning of the optic vesi-
cle, reduced expression of ventral eye and POM genes,
excessive cell proliferation, and tissue fusion defects (Mui
et al., 2005; Kim et al., 2007; McLaughlin et al., 2007; See
and Clagett-Dame, 2009; Lupo et al., 2011; Weiss et al.,
2012). Hence, multiple mechanisms are involved in optic
fissure closure, underscoring the complexity of this pro-
cess. However, a mechanistic understanding of the process
of optic fissure closure is still missing, and it is poorly
understood why this process sometimes fails. As the neu-
ral crest gives rise to many of the tissues in the developed
eye, it is reasonable to propose that these cells play an
important and critical role in the cellular and molecular
mechanisms underlying this step of ocular development.
Recent studies indicate that POM cells play a critical role
in choroid fissure closure (Etchevers et al., 2001; Weiss
FIGURE 5. A–C: Whole mount in situ hybridization of zebrafish embryos demonstrated
that cyp1b1 was expressed in the developing eye. At 24 hours post fertilization (hpf)
(A), cyp1b1 was expressed in the dorsal and ventral retina and RPE. Cyp1b1 expres-
sion peaked at 36 hpf (B), and at 48 hpf (C), cyp1b1 showed the highest expression
in the region of the ocular fissures. D–H: Injection of the RARE::mCherry reporter con-
struct in 1-cell stage zebrafish embryos showed RA activity in and around the develop-
ing eye at 48 hpf (F). Treatment with the pan-aldehyde dehydrogenase inhibitor, 10
lM diethylbenzaldehyde (DEAB) to decrease RA synthesis from 24 to 48 hpf
decreased mCherry expression (D), while the application of exogenous 50 nM RA
increased mCherry expression throughout the craniofacial region (E). The coinjection
of Cyp1b1 MO and the RARE::mCherry reporter construct in 1-cell stage embryos
decreased RA activity in the periocular region at 48 hpf (G). The injection of cyp1b1
mRNA diffusely increased mCherry expression at 48 hpf throughout the craniofacial
region and developing heart (H). I–L: Methylacrylate sections of 48 hpf zebrafish
embryos at 48 hpf demonstrated that MO knockdown of Cyp1b1 (I, K) mildly
decreased eye size, inhibited retinal differentiation, and decreased iris stromal cellular-
ity in the dorsal iridocorneal angle compared with controls (J, L).
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et al., 2012). However, what POM cells do, where POM
cells go, or how POM cells function during this process
remains unknown. To provide insight into this process, we
must first consider the development of coloboma from the
perspective of the potential role of NCCs in this ocular
defect.
RA AND Pitx2 DEFECTS LEAD TO FAILURES IN OPTIC FISSURE CLOSURE
As previously described, RA has long been implicated in
the development of the vertebrate eye. The requirement
for RA signaling in eye development was first described in
reports of severe congenital eye defects in vitamin A defi-
cient and/or RA-deficient human, pig, and rat fetuses
(Warkany and Schraffenberger, 1946). Indeed, the ASD
prominently observed in these individuals included agene-
sis of the lens, iris and corneal stroma, corneal endothe-
lium, the absence of the anterior chamber, and optic nerve
coloboma. These effects are phenocopied in mice, where
various combinations of RA-synthesis enzymes or RARs
are deleted, indicating that RA is required during choroid
fissure closure (See and Clagett-Dame, 2009). However,
tight control of RA levels appears to be critical for this
process as both RA deficiency and excess during embryo-
genesis induces colobomas in mice and zebrafish. In mice,
treatment of pregnant dams with RA changes gene expres-
sion along the proximal–distal axis of the fissure, thereby
altering specification of retina, retinal pigment epithelial,
choroid, and optic nerve. Further, in zebrafish, local deliv-
ery of RA to the eye not only resulted in coloboma, but
also induced ectopic fissure formation elsewhere in the
retina (Bohnsack and Kahana, 2013). As previously
described, RA targets the neural crest-derived POM that
surrounds the developing eye (Matt et al., 2005). Interest-
ingly, neural crest-specific knockout of all RAR genes in
mice causes colobomas and eversion of the ventral optic
cup, suggesting that RA acts via the POM to guide the
morphogenesis of the optic cup and closure of the choroid
fissure (Lohnes et al., 1994; Matt et al., 2008). In addition,
the known RA-target in the POM, PITX2, has also been
identified as playing a role in optic fissure closure (Gage
et al., 1999). Optic fissure closure is defective or signifi-
cantly delayed in Pitx2 null mutant mouse embryos (See
and Clagett-Dame, 2009; Kumar and Duester, 2010). Fur-
ther, conditional knockout of Pitx2 specifically in the neu-
ral crest also gives rise to colobomas (Gage et al., 2005;
Sclafani et al., 2006). Thus, the effects of RA and PITX2 on
not only anterior segment development, but also optic cup
morphogenesis and specifically ocular fissure closure are
via the neural crest.
Conclusions and Future perspectives
The most dynamic event in the morphogenesis of the
developing eye is the migration and differentiation of neu-
ral crest-derived periocular mesenchymal cells to provide
multiple mature cell lineages necessary for normal ocular
development and vision, including the corneal endothelium
and stroma, trabecular meshwork, ciliary body muscles,
and iris stroma (Hay, 1980; Cvekl and Tamm, 2004). The
POM also provides the essential signals for the patterning
of the neural ectoderm, including specification of the RPE
from the optic cup and differentiation of the optic stalk
from the neural ectoderm (Hay, 1980; Cvekl and Tamm,
2004). The derivation of these structures requires complex
interactions between the neural crest, neural ectoderm,
and surface ectoderm (Chow and Lang, 2001). Genetic or
acquired defects in the development or function of the
POM lead to debilitating vision loss and ocular disease,
emphasizing the importance of these cells in every aspect
of ocular development.
The use of animal models, particularly mice, chick, and
zebrafish, has improved our understanding of neural crest
development and importantly the pathogenesis of congeni-
tal eye diseases, such as ARS, congenital glaucoma, and
colobomas. The next step is to use this information to cre-
ate gene therapies or use stem cell technology to reverse
or bypass the molecular defects to restore vision in chil-
dren affected with these blinding diseases. Further, devel-
opmental studies will provide important insight into
regenerative treatments for degenerative diseases of neu-
ral crest-derived tissues such as keratoconus, Fuchs dys-
trophy, and adult-onset primary open-angle glaucoma.
Our understanding of neural crest contributions to the
eye should continue to be expanded. Through ophthalmic
genetics and congenital eye diseases, the knowledge
regarding the molecular regulation of neural crest contri-
butions to the anterior segment is growing. Another highly
important area of research regarding ocular neural crest
involves blood vessel formation. Studies in mice and quail
have demonstrated that pericytes and vascular smooth
muscle cells, which surround endothelial cells in the hya-
loid, retinal, choroidal, and optic nerve vasculature, are in
part, derived from NCCs (Etchevers et al., 2001; Gage
et al., 2005; Trost et al., 2013). Impaired blood vessel
development during eye development can lead to congeni-
tal eye diseases, including colobomas and microphthalmia.
These vascular support cells play a key role in tissue
homeostasis by stabilizing blood vessels, participating in
blood flow regulation, and mediating the formation of the
blood retina barrier (Saint-Geniez and D’Amore, 2004; Gar-
iano and Gardner, 2005; Kim et al., 2006; Jeong et al.,
2008; Hyoung Kim et al, 2011 ). In adults, loss of vascular
pericytes in retinal blood vessels is a key element in the
pathogenesis of diabetic retinopathy (Hammes et al., 2002;
Hammes, 2005; Beltramo and Porta, 2013;). Understand-
ing the contributions of the neural crest to blood vessels
in the developing eye holds promise for the treatment of
both congenital and degenerative eye diseases.
The neural crest is a dynamic embryonic stem cell
population that plays a critical role in ocular development.
The neural crest interacts with the surrounding neural
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ectoderm, surface ectoderm, and mesoderm and gives rise
to numerous components of the anterior segment of the
eye. Studies delineating neural crest development are key
for understanding the pathogenesis of congenital eye dis-
eases, such as those outlined in this review. Elucidating
these molecular signals will unlock the potential for novel
treatments for congenital diseases. Further, these pathways
also have implications in regenerative therapies for adult
degenerative diseases of neural crest-derivatives. Addi-
tional studies using animal models and genetic techniques
will expand our knowledge of this unique population of
stem cells and pioneer treatments.
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